3,770 Shares in Tempus AI, Inc. $TEM Purchased by Apollon Wealth Management LLC

Apollon Wealth Management LLC purchased a new position in Tempus AI, Inc. (NASDAQ:TEM) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 3,770 shares of the company’s stock, valued at approximately $240,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of TEM. University of Texas Texas AM Investment Management Co. bought a new position in shares of Tempus AI during the 1st quarter valued at about $33,000. Bartlett & CO. Wealth Management LLC lifted its stake in Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock valued at $39,000 after purchasing an additional 400 shares during the last quarter. Nemes Rush Group LLC bought a new stake in Tempus AI during the first quarter worth approximately $39,000. Continuum Advisory LLC bought a new stake in Tempus AI during the first quarter worth approximately $39,000. Finally, Farther Finance Advisors LLC grew its position in Tempus AI by 59.9% in the second quarter. Farther Finance Advisors LLC now owns 884 shares of the company’s stock worth $56,000 after buying an additional 331 shares during the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

TEM has been the subject of a number of recent research reports. Guggenheim increased their price objective on Tempus AI from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 26th. Bank of America lifted their target price on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. Morgan Stanley upped their target price on Tempus AI from $65.00 to $68.00 and gave the company an “overweight” rating in a report on Tuesday, August 12th. Needham & Company LLC reiterated a “buy” rating and issued a $70.00 price target on shares of Tempus AI in a research report on Friday, August 8th. Finally, HC Wainwright lifted their price target on Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a research note on Friday, September 12th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Tempus AI presently has an average rating of “Hold” and a consensus price target of $71.83.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 17,460 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $1,303,389.00. Following the transaction, the chief operating officer owned 839,180 shares in the company, valued at $62,644,787. The trade was a 2.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Andrew Polovin sold 5,398 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $402,960.70. Following the completion of the transaction, the executive vice president directly owned 132,056 shares in the company, valued at approximately $9,857,980.40. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 933,662 shares of company stock worth $68,070,993 over the last 90 days. 26.27% of the stock is currently owned by insiders.

Tempus AI Price Performance

Shares of TEM opened at $87.78 on Friday. The business’s 50-day moving average is $82.18 and its 200-day moving average is $66.23. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The company has a market capitalization of $15.25 billion, a price-to-earnings ratio of -73.76 and a beta of 4.87. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings data on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.01. The firm had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The firm’s revenue was up 89.5% on a year-over-year basis. During the same period in the previous year, the firm posted ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Equities research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.